Jane B. Acri, Ph.D.

Affiliations: 
Division of Pharmacotherapies and Medical Consequences of Drug Abuse National Institute on Drug Abuse 
Area:
Substance Abuse Disorders
Website:
http://www.usuhs.mil/mps/grunberg/labalumni.html
Google:
"Jane Acri"
Mean distance: 16.85 (cluster 29)
 
SNBCP

Parents

Sign in to add mentor
Neil E. Grunberg grad student 1986-1992 Uniformed Services University
 (Interactions of stress and nicotine on amplitude, pre-pulse inhibition, and habituation of the acoustic startle reflex)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Appel NM, Li SH, Holmes TH, et al. (2015) Dopamine D3 Receptor Antagonist (GSK598809) potentiates the hypertensive effects of cocaine in conscious, freely-moving dogs Journal of Pharmacology and Experimental Therapeutics. 354: 484-492
Skolnick P, White D, Acri JB. (2015) Emerging targets for stimulant use disorders: Where to invest in an era of constrained resources? Cns and Neurological Disorders - Drug Targets. 14: 691
Skolnick P, White D, Acri JB. (2015) Synopsis of expert opinions and conclusions Cns and Neurological Disorders - Drug Targets. 14: 773-776
Acri J. (2013) Evidence for the Contribution of D4 Receptors to Cocaine Self-Administration in Monkeys Catecholamine Research in the 21st Century: Abstracts and Graphical Abstracts, 10th International Catecholamine Symposium, 2012. 180
Acri JB. (2008) Introduction to a Symposium on Recent Advances in the Development of Medications for Drug Abuse Treatment in Honor of Jack H. Mendelson, MD Experimental and Clinical Psychopharmacology. 16: 443-445
Acri JB, Chiang CN, McCann DJ, et al. (2008) Summary of NIDA medications workshop: new opportunities for chemists and pharmacologists Drug and Alcohol Dependence. 92: 307-311
McCann DJ, Acri JB, Vocci FJ. (2008) Drug discovery and development for reward disorders: Views from government Animal and Translational Models For Cns Drug Discovery. 3: 23-40
Elkashef A, Biswas J, Acri JB, et al. (2007) Biotechnology and the treatment of addictive disorders: New opportunities Biodrugs. 21: 259-267
Vocci FJ, Acri J, Elkashef A. (2005) Medication development for addictive disorders: The state of the science American Journal of Psychiatry. 162: 1432-1440
Miller DK, Crooks PA, Teng L, et al. (2001) Lobeline inhibits the neurochemical and behavioral effects of amphetamine. The Journal of Pharmacology and Experimental Therapeutics. 296: 1023-34
See more...